Lindus Health raises $55M to ‘fix the broken clinical trial industry’

A four-year-old London startup backed by Peter Thiel has raised a $55 million Series B round as it sets about “fixing the broken clinical trial industry.” The announcement comes as artificial intelligence is shaping up to revolutionize drug discovery and development. Learn more about your ad choices. Visit podcastchoices.com/adchoices